Russell Investments Group’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-34,117
Closed -$120K 3116
2020
Q4
$120K Sell
34,117
-2,897
-8% -$10.2K ﹤0.01% 2844
2020
Q3
$148K Sell
37,014
-2,157
-6% -$8.63K ﹤0.01% 2889
2020
Q2
$106K Buy
39,171
+8,951
+30% +$24.2K ﹤0.01% 2872
2020
Q1
$63K Buy
+30,220
New +$63K ﹤0.01% 2838
2018
Q1
Sell
-1,500
Closed -$16K 2921
2017
Q4
$16K Sell
1,500
-4,904
-77% -$52.3K ﹤0.01% 2928
2017
Q3
$102K Sell
6,404
-2,882
-31% -$45.9K ﹤0.01% 2771
2017
Q2
$112K Buy
9,286
+2,105
+29% +$25.4K ﹤0.01% 2788
2017
Q1
$149K Sell
7,181
-19,229
-73% -$399K ﹤0.01% 2763
2016
Q4
$402K Buy
+26,410
New +$402K ﹤0.01% 2540